Carvana drops despite higher sales

Carvana's (CVNA) Q4 profitability loses traction; shares crater more than 20%. (00:14) DoorDash (DASH) sees double-digit growth in orders, GOV; sets upbeat Q1 guidance. (01:31) Moderna (MRNA) gains as FDA backtracks and accepts flu shot for review. (02:14)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers Thursday: OXY, DASH, and moreGameStop's Ryan Cohen takes on the 'hollow men' of corporate boardroomsShift away from EVs continues to cost Avis BudgetFigma targets 30% revenue growth for 2026 as AI adoption acceleratesSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.